Mayo-Wilson Evan, Imdad Aamer, Junior Jean, Dean Sohni, Bhutta Zulfiqar A
Department of Epidemiology, Center for Clinical Trials and Evidence Synthesis, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA.
BMJ Open. 2014 Jun 19;4(6):e004647. doi: 10.1136/bmjopen-2013-004647.
Zinc deficiency is widespread, and preventive supplementation may have benefits in young children. Effects for children over 5 years of age, and effects when coadministered with other micronutrients are uncertain. These are obstacles to scale-up. This review seeks to determine if preventive supplementation reduces mortality and morbidity for children aged 6 months to 12 years.
Systematic review conducted with the Cochrane Developmental, Psychosocial and Learning Problems Group. Two reviewers independently assessed studies. Meta-analyses were performed for mortality, illness and side effects.
We searched multiple databases, including CENTRAL and MEDLINE in January 2013. Authors were contacted for missing information.
Randomised trials of preventive zinc supplementation. Hospitalised children and children with chronic diseases were excluded.
80 randomised trials with 205 401 participants were included. There was a small but non-significant effect on all-cause mortality (risk ratio (RR) 0.95 (95% CI 0.86 to 1.05)). Supplementation may reduce incidence of all-cause diarrhoea (RR 0.87 (0.85 to 0.89)), but there was evidence of reporting bias. There was no evidence of an effect of incidence or prevalence of respiratory infections or malaria. There was moderate quality evidence of a very small effect on linear growth (standardised mean difference 0.09 (0.06 to 0.13)) and an increase in vomiting (RR 1.29 (1.14 to 1.46)). There was no evidence of an effect on iron status. Comparing zinc with and without iron cosupplementation and direct comparisons of zinc plus iron versus zinc administered alone favoured cointervention for some outcomes and zinc alone for other outcomes. Effects may be larger for children over 1 year of age, but most differences were not significant.
Benefits of preventive zinc supplementation may outweigh any potentially adverse effects in areas where risk of zinc deficiency is high. Further research should determine optimal intervention characteristics and delivery strategies.
锌缺乏症广泛存在,预防性补充锌可能对幼儿有益。对于5岁以上儿童的影响以及与其他微量营养素同时服用时的影响尚不确定。这些都是扩大规模的障碍。本综述旨在确定预防性补充锌是否能降低6个月至12岁儿童的死亡率和发病率。
由Cochrane发育、心理社会和学习问题小组进行系统综述。两名评审员独立评估研究。对死亡率、疾病和副作用进行荟萃分析。
我们在2013年1月检索了多个数据库,包括CENTRAL和MEDLINE。联系作者获取缺失信息。
预防性锌补充的随机试验。排除住院儿童和患有慢性病的儿童。
纳入了80项随机试验,共205401名参与者。对全因死亡率有微小但无显著影响(风险比(RR)0.95(95%置信区间0.86至1.05))。补充锌可能降低全因腹泻的发生率(RR 0.87(0.85至0.89)),但有报告偏倚的证据。没有证据表明补充锌对呼吸道感染或疟疾的发生率或患病率有影响。有中等质量的证据表明对线性生长有非常小的影响(标准化均值差0.09(0.06至0.13))且呕吐增加(RR 1.29(1.14至1.46))。没有证据表明对铁状态有影响。比较同时补充锌和铁与不补充铁以及直接比较锌加铁与单独补充锌,对于某些结局,联合干预更有利,而对于其他结局,单独补充锌更有利。对于1岁以上儿童影响可能更大,但大多数差异不显著。
在锌缺乏风险高的地区,预防性补充锌的益处可能超过任何潜在的不良反应。进一步研究应确定最佳干预特征和实施策略。